Reaction Details |
| Report a problem with these data |
Target | Vasopressin V1a receptor |
---|
Ligand | BDBM521137 |
---|
Substrate/Competitor | n/a |
---|
Meas. Tech. | Cellular In Vitro Assay for Determining Vasopressin Receptor Activity |
---|
IC50 | 3.40±n/a nM |
---|
Citation | Collin-Kroepelin, M; Kolkhof, P; Neubauer, T; Fuerstner, C; Pook, E; Wittwer, MB; Schirmer, H; Tinel, H Substituted triazole derivatives and uses thereof US Patent US11149023 Publication Date 10/19/2021 |
---|
More Info.: | Get all data from this article, Assay Method |
---|
|
Vasopressin V1a receptor |
---|
Name: | Vasopressin V1a receptor |
Synonyms: | AVPR V1a | AVPR1 | AVPR1A | Antidiuretic hormone receptor 1a | V1AR_HUMAN | V1aR | VASOPRESSIN V1A | Vascular/hepatic-type arginine vasopressin receptor | Vasopressin V1 receptor | Vasopressin V1a receptor | Vasopressin receptor |
Type: | Receptor |
Mol. Mass.: | 46820.18 |
Organism: | Homo sapiens (Human) |
Description: | P37288 |
Residue: | 418 |
Sequence: | MRLSAGPDAGPSGNSSPWWPLATGAGNTSREAEALGEGNGPPRDVRNEELAKLEIAVLAV
TFAVAVLGNSSVLLALHRTPRKTSRMHLFIRHLSLADLAVAFFQVLPQMCWDITYRFRGP
DWLCRVVKHLQVFGMFASAYMLVVMTADRYIAVCHPLKTLQQPARRSRLMIAAAWVLSFV
LSTPQYFVFSMIEVNNVTKARDCWATFIQPWGSRAYVTWMTGGIFVAPVVILGTCYGFIC
YNIWCNVRGKTASRQSKGAEQAGVAFQKGFLLAPCVSSVKSISRAKIRTVKMTFVIVTAY
IVCWAPFFIIQMWSVWDPMSVWTESENPTITITALLGSLNSCCNPWIYMFFSGHLLQDCV
QSFPCCQNMKEKFNKEDTDSMSRRQTFYSNNRSPTNSTGMWKDSPKSSKSIKFIPVST
|
|
|
BDBM521137 |
---|
n/a |
---|
Name | BDBM521137 |
Synonyms: | N-{3-[3-(4-Chlorophenyl)-1-{[1-(3-chloropyridin-2-yl)-1H-1,2,4-triazol-3-yl]methyl}-5-oxo-1,5-dihydro-4H-1,2,4-triazol-4-yl]-1,1,1-trifluoropropan-2-yl}-3,4,4-trifluorobut-3-enamide (Racemate) | US11149023, Example 31 |
Type | Small organic molecule |
Emp. Form. | C23H16Cl2F6N8O2 |
Mol. Mass. | 621.322 |
SMILES | F\[#6](F)=[#6](/F)-[#6]-[#6](=O)-[#7]-[#6](-[#6]-n1c(nn(-[#6]-c2ncn(n2)-c2ncccc2Cl)c1=O)-c1ccc(Cl)cc1)C(F)(F)F |
Structure |
|